VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q72555205 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233158.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q72555205‏
024 ‎‡a 0000-0002-0626-7502‏ ‎‡2 orcid‏
024 ‎‡a 7102174904‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q72555205‏
100 0 ‎‡a Miguel Ángel García Pérez‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Miguel Ángel García Pérez‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A C >T polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women‏
670 ‎‡a Author's A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans.‏
670 ‎‡a Author's A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency‏
670 ‎‡a Author's A predictive model for women's assisted fecundity before starting the first IVF/ICSI treatment cycle‏
670 ‎‡a Author's A splicing mutation, a nonsense mutation (Y167X) and two missense mutations (I159T and A209V) in Spanish patients with ornithine transcarbamylase deficiency‏
670 ‎‡a Author's A translational approach from an animal model identifies CD80 as a candidate gene for the study of bone phenotypes in postmenopausal women.‏
670 ‎‡a Author's Absence of long-term effects of reproduction on longevity in the mouse model‏
670 ‎‡a Author's Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice‏
670 ‎‡a Author's Assisted reproductive technology results: why are live-birth percentages so low?‏
670 ‎‡a Author's Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women‏
670 ‎‡a Author's Association of ACACB polymorphisms with obesity and diabetes‏
670 ‎‡a Author's Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.‏
670 ‎‡a Author's Beneficial effects of dithiothreitol on relative levels of glutathione S-transferase activity and thiols in oocytes, and cell number, DNA fragmentation and allocation at the blastocyst stage in the mouse.‏
670 ‎‡a Author's Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture.‏
670 ‎‡a Author's Bone turnover markers and PTH levels in surgical versus natural menopause.‏
670 ‎‡a Author's Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients‏
670 ‎‡a Author's Cathepsin C gene: First compound heterozygous patient with Papillon-Lefèvre syndrome and a novel symptomless mutation‏
670 ‎‡a Author's Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles.‏
670 ‎‡a Author's Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women‏
670 ‎‡a Author's Comparative effects of 17beta-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice.‏
670 ‎‡a Author's Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice‏
670 ‎‡a Author's Correction to: a predictive model for women's assisted fecundity before starting the first IVF/ICSI treatment cycle‏
670 ‎‡a Author's Cumulative probabilities of live birth across multiple complete IVF/ICSI cycles: a call for attention‏
670 ‎‡a Author's Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies‏
670 ‎‡a Author's Delayed fatherhood in mice decreases reproductive fitness and longevity of offspring.‏
670 ‎‡a Author's Demonstration of the spf-ash mutation in Spanish patients with ornithine transcarbamylase deficiency of moderate severity‏
670 ‎‡a Author's Diet to Reduce the Metabolic Syndrome Associated with Menopause. The Logic for Olive Oil‏
670 ‎‡a Author's Effect of dietary supplementation with a mixture of Vitamins C and E on fertilization of tertiary butyl hydroperoxide-treated oocytes and parthenogenetic activation in the mouse‏
670 ‎‡a Author's Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling.‏
670 ‎‡a Author's Endocrinology and physiology of pseudocyesis‏
670 ‎‡a Author's Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.‏
670 ‎‡a Author's Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells‏
670 ‎‡a Author's Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{ Alpha }.‏
670 ‎‡a Author's Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells.‏
670 ‎‡a Author's Fourteen years' follow-up of an autoimmune patient lacking the CD3 gamma subunit of the T-lymphocyte receptor‏
670 ‎‡a Author's Gene expression profile induced by ovariectomy in bone marrow of mice: a functional approach to identify new candidate genes associated to osteoporosis risk in women‏
670 ‎‡a Author's Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women.‏
670 ‎‡a Author's Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency‏
670 ‎‡a Author's Isoflavones and cardiovascular disease.‏
670 ‎‡a Author's Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line.‏
670 ‎‡a Author's Long-term effects of delayed fatherhood in mice on postnatal development and behavioral traits of offspring.‏
670 ‎‡a Author's Missense mutations in codon 225 of ornithine transcarbamylase‏
670 ‎‡a Author's Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency‏
670 ‎‡a Author's Mutations of CD40 ligand in two patients with hyper-IgM syndrome‏
670 ‎‡a Author's N-acetyl-L-glutamate in brain: assay, levels, and regional and subcellular distribution‏
670 ‎‡a Author's Necrotic adnexal tumor after detorsion in pregnancy: excise or leave?‏
670 ‎‡a Author's No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells.‏
670 ‎‡a Author's Note of clarification: Potential risks to offspring of intrauterine exposure to maternal age-related obstetric complications.‏
670 ‎‡a Author's Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density‏
670 ‎‡a Author's Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments‏
670 ‎‡a Author's Potential risks to offspring of intrauterine exposure to maternal age-related obstetric complications‏
670 ‎‡a Author's Progestogens reduce thromboxane production by cultured human endothelial cells.‏
670 ‎‡a Author's Progestogens stimulate prostacyclin production by human endothelial cells.‏
670 ‎‡a Author's Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women.‏
670 ‎‡a Author's Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women‏
670 ‎‡a Author's Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families‏
670 ‎‡a Author's Replication study of three functional polymorphisms associated with bone mineral density in a cohort of Spanish women.‏
670 ‎‡a Author's Role of Nijmegen breakage syndrome protein in specific T-lymphocyte activation pathways‏
670 ‎‡a Author's Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture.‏
670 ‎‡a Author's Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.‏
670 ‎‡a Author's SNPs in bone-related miRNAs are associated with the osteoporotic phenotype‏
670 ‎‡a Author's Surgical planning after sleep versus awake techniques in patients with obstructive sleep apnea.‏
670 ‎‡a Author's The Asn19Lys substitution in the osteoclast inhibitory lectin‏
670 ‎‡a Author's The Asn19Lys substitution in the osteoclast inhibitory lectin (OCIL) gene is associated with a reduction of bone mineral density in postmenopausal women.‏
670 ‎‡a Author's The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?‏
670 ‎‡a Author's The role of CD40 and CD40L in bone mineral density and in osteoporosis risk: A genetic and functional study‏
670 ‎‡a Author's Toxina Botulínica A en el tratamiento de la hiperhidrosis primaria: estudio prospectivo de 52 pacientes‏
670 ‎‡a Author's Transdermal estradiol reduces F2 Alpha -isoprostane levels in postmenopausal women.‏
670 ‎‡a Author's Transient regional osteoporosis.‏
670 ‎‡a Author's Unpredicted ovulations and conceptions during early pregnancy: an explanatory mechanism of human superfetation‏
670 ‎‡a Author's Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women‏
670 ‎‡a Author's Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication‏
670 ‎‡a Author's Women's morbid conditions are associated with decreased odds of live birth in the first IVF/ICSI treatment: a retrospective single-center study‏
909 ‎‡a (orcid) 0000000206267502‏ ‎‡9 1‏
909 ‎‡a (scopus) 7102174904‏ ‎‡9 1‏
919 ‎‡a missensemutationsincodon225ofornithinetranscarbamylase‏ ‎‡A Missense mutations in codon 225 of ornithine transcarbamylase‏ ‎‡9 1‏
919 ‎‡a 100tpolymorphismlocatedatposition1ofthekozaksequenceofcd40geneisassociatedwithlowbonemassinspanishpostmenopausalwomen‏ ‎‡A A C >T polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women‏ ‎‡9 1‏
919 ‎‡a novelcd18genomicdeletioninapatientwithsevereleucocyteadhesiondeficiencyapossiblecd2lymphocytefunctionassociatedantigen1functionalassociationinhumans‏ ‎‡A A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans.‏ ‎‡9 1‏
919 ‎‡a pointmutationinadomainofgammainterferonreceptor1provokessevereimmunodeficiency‏ ‎‡A A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency‏ ‎‡9 1‏
919 ‎‡a predictivemodelforwomensassistedfecunditybeforestartingthe1ivficsitreatmentcycle‏ ‎‡A A predictive model for women's assisted fecundity before starting the first IVF/ICSI treatment cycle‏ ‎‡9 1‏
919 ‎‡a splicingmutationanonsensemutationy167xand2missensemutationsi159tanda209vinspanishpatientswithornithinetranscarbamylasedeficiency‏ ‎‡A A splicing mutation, a nonsense mutation (Y167X) and two missense mutations (I159T and A209V) in Spanish patients with ornithine transcarbamylase deficiency‏ ‎‡9 1‏
919 ‎‡a translationalapproachfromananimalmodelidentifiescd80asacandidategeneforthestudyofbonephenotypesinpostmenopausalwomen‏ ‎‡A A translational approach from an animal model identifies CD80 as a candidate gene for the study of bone phenotypes in postmenopausal women.‏ ‎‡9 1‏
919 ‎‡a absenceoflongtermeffectsofreproductiononlongevityinthemousemodel‏ ‎‡A Absence of long-term effects of reproduction on longevity in the mouse model‏ ‎‡9 1‏
919 ‎‡a alterationsinthephenotypeandfunctionofimmunecellsinovariectomyinducedosteopenicmice‏ ‎‡A Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice‏ ‎‡9 1‏
919 ‎‡a assistedreproductivetechnologyresultswhyarelivebirthpercentagessolow‏ ‎‡A Assisted reproductive technology results: why are live-birth percentages so low?‏ ‎‡9 1‏
919 ‎‡a associationofasinglenucleotidepolymorphismofrankgenewithbloodpressureinspanishwomen‏ ‎‡A Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women‏ ‎‡9 1‏
919 ‎‡a associationofacacbpolymorphismswithobesityanddiabetes‏ ‎‡A Association of ACACB polymorphisms with obesity and diabetes‏ ‎‡9 1‏
919 ‎‡a associationsbetweenaromatasecyp19rs10046polymorphismandbreastcancerriskfromacasecontroltoametaanalysisof20098subjects‏ ‎‡A Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.‏ ‎‡9 1‏
919 ‎‡a beneficialeffectsofdithiothreitolonrelativelevelsofglutathionestransferaseactivityandthiolsinoocytesandcellnumberdnafragmentationandallocationattheblastocyststageinthemouse‏ ‎‡A Beneficial effects of dithiothreitol on relative levels of glutathione S-transferase activity and thiols in oocytes, and cell number, DNA fragmentation and allocation at the blastocyst stage in the mouse.‏ ‎‡9 1‏
919 ‎‡a bonemetabolicchangesduringpregnancyaperiodofvulnerabilitytoosteoporosisandfracture‏ ‎‡A Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture.‏ ‎‡9 1‏
919 ‎‡a boneturnovermarkersandpthlevelsinsurgicalversusnaturalmenopause‏ ‎‡A Bone turnover markers and PTH levels in surgical versus natural menopause.‏ ‎‡9 1‏
919 ‎‡a botulinumtoxintypeaforthetreatmentofprimaryhyperhidrosisaprospectivestudyof52patients‏ ‎‡A Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients‏ ‎‡9 1‏
919 ‎‡a cathepsin100gene1compoundheterozygouspatientwithpapillonlefevresyndromeandanovelsymptomlessmutation‏ ‎‡A Cathepsin C gene: First compound heterozygous patient with Papillon-Lefèvre syndrome and a novel symptomless mutation‏ ‎‡9 1‏
919 ‎‡a changesinsexratiofromfertilizationtobirthinassistedreproductivetreatmentcycles‏ ‎‡A Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles.‏ ‎‡9 1‏
919 ‎‡a commonpolymorphismsratherthanraregeneticvariantsoftherunx2geneareassociatedwithfemoralneckbmdinspanishwomen‏ ‎‡A Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women‏ ‎‡9 1‏
919 ‎‡a comparativeeffectsof17betaestradiolraloxifeneandgenisteinonbone3dmicroarchitectureandvolumetricbonemineraldensityintheovariectomizedmice‏ ‎‡A Comparative effects of 17beta-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice.‏ ‎‡9 1‏
919 ‎‡a comparativeeffectsofestradiolraloxifeneandgenisteinontheuterusofovariectomizedmice‏ ‎‡A Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice‏ ‎‡9 1‏
919 ‎‡a correctiontoapredictivemodelforwomensassistedfecunditybeforestartingthe1ivficsitreatmentcycle‏ ‎‡A Correction to: a predictive model for women's assisted fecundity before starting the first IVF/ICSI treatment cycle‏ ‎‡9 1‏
919 ‎‡a cumulativeprobabilitiesoflivebirthacrossmultiplecompleteivficsicyclesacallforattention‏ ‎‡A Cumulative probabilities of live birth across multiple complete IVF/ICSI cycles: a call for attention‏ ‎‡9 1‏
919 ‎‡a deficienciesinreportingresultsoflesbiansandgaysafterdonorintrauterineinseminationandassistedreproductivetechnologytreatmentsareviewofthe1emergingstudies‏ ‎‡A Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies‏ ‎‡9 1‏
919 ‎‡a delayedfatherhoodinmicedecreasesreproductivefitnessandlongevityofoffspring‏ ‎‡A Delayed fatherhood in mice decreases reproductive fitness and longevity of offspring.‏ ‎‡9 1‏
919 ‎‡a demonstrationofthespfashmutationinspanishpatientswithornithinetranscarbamylasedeficiencyofmoderateseverity‏ ‎‡A Demonstration of the spf-ash mutation in Spanish patients with ornithine transcarbamylase deficiency of moderate severity‏ ‎‡9 1‏
919 ‎‡a diettoreducethemetabolicsyndromeassociatedwithmenopausethelogicforoliveoil‏ ‎‡A Diet to Reduce the Metabolic Syndrome Associated with Menopause. The Logic for Olive Oil‏ ‎‡9 1‏
919 ‎‡a effectofdietarysupplementationwithamixtureofvitamins100andeonfertilizationoftertiarybutylhydroperoxidetreatedoocytesandparthenogeneticactivationinthemouse‏ ‎‡A Effect of dietary supplementation with a mixture of Vitamins C and E on fertilization of tertiary butyl hydroperoxide-treated oocytes and parthenogenetic activation in the mouse‏ ‎‡9 1‏
919 ‎‡a effectsofadministrationofhormonetherapyorraloxifeneontheimmunesystemandonbiochemicalmarkersofboneremodeling‏ ‎‡A Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling.‏ ‎‡9 1‏
919 ‎‡a endocrinologyandphysiologyofpseudocyesis‏ ‎‡A Endocrinology and physiology of pseudocyesis‏ ‎‡9 1‏
919 ‎‡a endometrialresponsetoconcurrenttreatmentwithvaginalprogesteroneandtransdermalestradiol‏ ‎‡A Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.‏ ‎‡9 1‏
919 ‎‡a estradiolcounteractsoxidizedldlinducedasymmetricdimethylarginineproductionbyculturedhumanendothelialcells‏ ‎‡A Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells‏ ‎‡9 1‏
919 ‎‡a estradiolselectivelystimulatesendothelialprostacyclinproductionthroughestrogenreceptor Alpha ‏ ‎‡A Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{ Alpha }.‏ ‎‡9 1‏
919 ‎‡a estradiolstimulatesvasodilatoryandmetabolicpathwaysinculturedhumanendothelialcells‏ ‎‡A Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells.‏ ‎‡9 1‏
919 ‎‡a 14yearsfollowupofanautoimmunepatientlackingthecd3gammasubunitofthetlymphocytereceptor‏ ‎‡A Fourteen years' follow-up of an autoimmune patient lacking the CD3 gamma subunit of the T-lymphocyte receptor‏ ‎‡9 1‏
919 ‎‡a geneexpressionprofileinducedbyovariectomyinbonemarrowofmiceafunctionalapproachtoidentifynewcandidategenesassociatedtoosteoporosisriskinwomen‏ ‎‡A Gene expression profile induced by ovariectomy in bone marrow of mice: a functional approach to identify new candidate genes associated to osteoporosis risk in women‏ ‎‡9 1‏
919 ‎‡a genegeneinteractionbetweencd40andcd40lreducesbonemineraldensityandincreasesosteoporosisriskinwomen‏ ‎‡A Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women.‏ ‎‡9 1‏
919 ‎‡a identificationofacytogeneticdeletionandof4novelmutationsq69xi172fg188vg197raffectingthegeneforornithinetranscarbamylaseotcinspanishpatientswithotcdeficiency‏ ‎‡A Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency‏ ‎‡9 1‏
919 ‎‡a isopropanoliccimicifugaracemosaisfavorableonbonemarkersbutneutralonanosteoblasticcellline‏ ‎‡A Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line.‏ ‎‡9 1‏
919 ‎‡a longtermeffectsofdelayedfatherhoodinmiceonpostnataldevelopmentandbehavioraltraitsofoffspring‏ ‎‡A Long-term effects of delayed fatherhood in mice on postnatal development and behavioral traits of offspring.‏ ‎‡9 1‏
919 ‎‡a missensemutationsincodon225ofornithinetranscarbamylaseotcresultindecreasedamountsofotcproteinahypothesisonthemolecularmechanismoftheotcdeficiency‏ ‎‡A Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency‏ ‎‡9 1‏
919 ‎‡a mutationsofcd40ligandin2patientswithhyperigmsyndrome‏ ‎‡A Mutations of CD40 ligand in two patients with hyper-IgM syndrome‏ ‎‡9 1‏
919 ‎‡a nacetyl50glutamateinbrainassaylevelsandregionalandsubcellulardistribution‏ ‎‡A N-acetyl-L-glutamate in brain: assay, levels, and regional and subcellular distribution‏ ‎‡9 1‏
919 ‎‡a necroticadnexaltumorafterdetorsioninpregnancyexciseorleave‏ ‎‡A Necrotic adnexal tumor after detorsion in pregnancy: excise or leave?‏ ‎‡9 1‏
919 ‎‡a noeffectofcimicifugaracemosaextractonseruminterleukin6levelsandprostacyclinproductionbyhumanendothelialcells‏ ‎‡A No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells.‏ ‎‡9 1‏
919 ‎‡a noteofclarificationpotentialriskstooffspringofintrauterineexposuretomaternalagerelatedobstetriccomplications‏ ‎‡A Note of clarification: Potential risks to offspring of intrauterine exposure to maternal age-related obstetric complications.‏ ‎‡9 1‏
919 ‎‡a nuclearreceptornr5a2andbonegeneexpressionandassociationwithbonemineraldensity‏ ‎‡A Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density‏ ‎‡9 1‏
919 ‎‡a obstetricandoffspringrisksofwomensmorbidconditionslinkedtoprioranticancertreatments‏ ‎‡A Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments‏ ‎‡9 1‏
919 ‎‡a potentialriskstooffspringofintrauterineexposuretomaternalagerelatedobstetriccomplications‏ ‎‡A Potential risks to offspring of intrauterine exposure to maternal age-related obstetric complications‏ ‎‡9 1‏
919 ‎‡a progestogensreducethromboxaneproductionbyculturedhumanendothelialcells‏ ‎‡A Progestogens reduce thromboxane production by cultured human endothelial cells.‏ ‎‡9 1‏
919 ‎‡a progestogensstimulateprostacyclinproductionbyhumanendothelialcells‏ ‎‡A Progestogens stimulate prostacyclin production by human endothelial cells.‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenpthsexsteroidandboneturnovermarkermeasurementsandbonedensityinrecentlypostmenopausalwomen‏ ‎‡A Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women.‏ ‎‡9 1‏
919 ‎‡a relationshipofsclerostinandsecretedfrizzledproteinpolymorphismswithbonemineraldensityanassociationstudywithreplicationinpostmenopausalwomen‏ ‎‡A Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women‏ ‎‡9 1‏
919 ‎‡a relativefrequencyofmutationscausingornithinetranscarbamylasedeficiencyin78families‏ ‎‡A Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families‏ ‎‡9 1‏
919 ‎‡a replicationstudyof3functionalpolymorphismsassociatedwithbonemineraldensityinacohortofspanishwomen‏ ‎‡A Replication study of three functional polymorphisms associated with bone mineral density in a cohort of Spanish women.‏ ‎‡9 1‏
919 ‎‡a roleofnijmegenbreakagesyndromeproteininspecifictlymphocyteactivationpathways‏ ‎‡A Role of Nijmegen breakage syndrome protein in specific T-lymphocyte activation pathways‏ ‎‡9 1‏
919 ‎‡a serumcirculatingmicrornasasbiomarkersofosteoporoticfracture‏ ‎‡A Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture.‏ ‎‡9 1‏
919 ‎‡a similarefficacyoflowandstandarddosesoftransdermalestradiolincontrollingboneturnoverinpostmenopausalwomen‏ ‎‡A Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.‏ ‎‡9 1‏
919 ‎‡a snpsinbonerelatedmirnasareassociatedwiththeosteoporoticphenotype‏ ‎‡A SNPs in bone-related miRNAs are associated with the osteoporotic phenotype‏ ‎‡9 1‏
919 ‎‡a surgicalplanningaftersleepversusawaketechniquesinpatientswithobstructivesleepapnea‏ ‎‡A Surgical planning after sleep versus awake techniques in patients with obstructive sleep apnea.‏ ‎‡9 1‏
919 ‎‡a asn19lyssubstitutionintheosteoclastinhibitorylectin‏ ‎‡A The Asn19Lys substitution in the osteoclast inhibitory lectin‏ ‎‡9 1‏
919 ‎‡a asn19lyssubstitutionintheosteoclastinhibitorylectinocilgeneisassociatedwithareductionofbonemineraldensityinpostmenopausalwomen‏ ‎‡A The Asn19Lys substitution in the osteoclast inhibitory lectin (OCIL) gene is associated with a reduction of bone mineral density in postmenopausal women.‏ ‎‡9 1‏
919 ‎‡a newfrontierofboneformationabreakthroughinpostmenopausalosteoporosis‏ ‎‡A The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?‏ ‎‡9 1‏
919 ‎‡a roleofcd40andcd40linbonemineraldensityandinosteoporosisriskageneticandfunctionalstudy‏ ‎‡A The role of CD40 and CD40L in bone mineral density and in osteoporosis risk: A genetic and functional study‏ ‎‡9 1‏
919 ‎‡a toxinabotulinicaaeneltratamientodelahiperhidrosisprimariaestudioprospectivode52pacientes‏ ‎‡A Toxina Botulínica A en el tratamiento de la hiperhidrosis primaria: estudio prospectivo de 52 pacientes‏ ‎‡9 1‏
919 ‎‡a transdermalestradiolreducesf2 Alpha isoprostanelevelsinpostmenopausalwomen‏ ‎‡A Transdermal estradiol reduces F2 Alpha -isoprostane levels in postmenopausal women.‏ ‎‡9 1‏
919 ‎‡a transientregionalosteoporosis‏ ‎‡A Transient regional osteoporosis.‏ ‎‡9 1‏
919 ‎‡a unpredictedovulationsandconceptionsduringearlypregnancyanexplanatorymechanismofhumansuperfetation‏ ‎‡A Unpredicted ovulations and conceptions during early pregnancy: an explanatory mechanism of human superfetation‏ ‎‡9 1‏
919 ‎‡a vitamin500levelsinmediterraneanbreastcancerpatientscomparedwiththoseinhealthywomen‏ ‎‡A Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women‏ ‎‡9 1‏
919 ‎‡a wntreceptorsbonemassandfracturesgenewideassociationanalysisoflrp5andlrp6polymorphismswithreplication‏ ‎‡A Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication‏ ‎‡9 1‏
919 ‎‡a womensmorbidconditionsareassociatedwithdecreasedoddsoflivebirthinthe1ivficsitreatmentaretrospectivesinglecenterstudy‏ ‎‡A Women's morbid conditions are associated with decreased odds of live birth in the first IVF/ICSI treatment: a retrospective single-center study‏ ‎‡9 1‏
919 ‎‡a isoflavonesandcardiovasculardisease‏ ‎‡A Isoflavones and cardiovascular disease.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000081541116‏
996 ‎‡2 RERO|A000134224‏
996 ‎‡2 SUDOC|069829195‏
996 ‎‡2 ISNI|0000000109267295‏
996 ‎‡2 CAOONL|ncf11199664‏
996 ‎‡2 DNB|1057528404‏
996 ‎‡2 LC|nr2005013743‏
996 ‎‡2 LC|no 96044865‏
996 ‎‡2 LC|no2014139484‏
996 ‎‡2 J9U|987007435947305171‏
996 ‎‡2 ISNI|0000000076430649‏
996 ‎‡2 SUDOC|029391881‏
996 ‎‡2 BNE|XX1478255‏
996 ‎‡2 ISNI|0000000031947177‏
996 ‎‡2 BNE|XX1478617‏
996 ‎‡2 DNB|13219452X‏
996 ‎‡2 CAOONL|ncf13766140‏
996 ‎‡2 ISNI|0000000036155830‏
996 ‎‡2 LC|no2013141997‏
996 ‎‡2 BNE|XX944033‏
996 ‎‡2 DNB|1338022598‏
996 ‎‡2 LC|n 2008181526‏
996 ‎‡2 NUKAT|n 2016154801‏
996 ‎‡2 ISNI|0000000114740112‏
996 ‎‡2 LC|n 2014014955‏
996 ‎‡2 PTBNP|1915924‏
996 ‎‡2 BNE|XX1042325‏
996 ‎‡2 DNB|103660358X‏
996 ‎‡2 BNE|XX1097610‏
996 ‎‡2 DNB|1057338370‏
996 ‎‡2 ISNI|0000000118720274‏
996 ‎‡2 CAOONL|ncf11679581‏
996 ‎‡2 BNF|17165694‏
996 ‎‡2 ISNI|0000000044930876‏
996 ‎‡2 BNE|XX1721872‏
996 ‎‡2 LC|ns2011002017‏
996 ‎‡2 ISNI|0000000066021892‏
996 ‎‡2 BNC|981060894537406706‏
996 ‎‡2 DNB|136437192‏
996 ‎‡2 DNB|136699863‏
996 ‎‡2 PTBNP|1445176‏
996 ‎‡2 ISNI|0000000022912001‏
996 ‎‡2 BNE|XX5757005‏
996 ‎‡2 DNB|1038116929‏
996 ‎‡2 ISNI|000000003035103X‏
996 ‎‡2 BNE|XX1669264‏
996 ‎‡2 LC|no2023080149‏
996 ‎‡2 ISNI|0000000060844193‏
996 ‎‡2 LC|n 80071550‏
996 ‎‡2 BNF|12111375‏
996 ‎‡2 LC|n 2016009074‏
996 ‎‡2 LC|no2018092824‏
996 ‎‡2 LC|no2004037085‏
996 ‎‡2 SUDOC|117654728‏
996 ‎‡2 BNE|XX1399396‏
996 ‎‡2 ISNI|0000000059684591‏
996 ‎‡2 BNE|XX1464197‏
996 ‎‡2 SUDOC|185075509‏
996 ‎‡2 SUDOC|188433376‏
996 ‎‡2 ISNI|0000000078843092‏
996 ‎‡2 LC|n 2012049215‏
996 ‎‡2 BNE|XX1531980‏
996 ‎‡2 J9U|987007456795105171‏
996 ‎‡2 BNE|XX1495691‏
996 ‎‡2 ISNI|000000006965891X‏
996 ‎‡2 BNC|981058595262906706‏
996 ‎‡2 BNE|XX893169‏
996 ‎‡2 BNC|981058608604006706‏
996 ‎‡2 JPG|500127323‏
996 ‎‡2 LNB|LNC10-000256350‏
996 ‎‡2 ISNI|0000000059410582‏
996 ‎‡2 LC|no2012111683‏
996 ‎‡2 BNCHL|10000000000000000197895‏
996 ‎‡2 RERO|A010387091‏
996 ‎‡2 PLWABN|9810656982005606‏
996 ‎‡2 ISNI|0000000059561647‏
996 ‎‡2 RERO|A024302903‏
996 ‎‡2 DNB|1191902226‏
996 ‎‡2 BNE|XX947544‏
996 ‎‡2 NTA|160663008‏
996 ‎‡2 BNE|XX5431480‏
996 ‎‡2 RERO|A003695517‏
996 ‎‡2 PTBNP|1147764‏
996 ‎‡2 BNE|XX5184104‏
996 ‎‡2 RERO|A025078228‏
996 ‎‡2 BNE|XX6298572‏
996 ‎‡2 LC|no2010155166‏
996 ‎‡2 BNE|XX1759786‏
996 ‎‡2 BNE|XX4660757‏
996 ‎‡2 BNE|XX1758511‏
996 ‎‡2 BNC|981058612926806706‏
996 ‎‡2 BNE|XX1241319‏
996 ‎‡2 BNE|XX876177‏
996 ‎‡2 BNE|XX1556335‏
996 ‎‡2 BNE|XX6296472‏
996 ‎‡2 BNC|981058581169006706‏
996 ‎‡2 ISNI|0000000060557725‏
996 ‎‡2 BNE|XX5095255‏
996 ‎‡2 ISNI|0000000072000713‏
996 ‎‡2 ISNI|0000000023178419‏
996 ‎‡2 BNC|981058516778306706‏
996 ‎‡2 DNB|1055373411‏
996 ‎‡2 ISNI|000000005102402X‏
996 ‎‡2 BNE|XX6320114‏
996 ‎‡2 ISNI|0000000355999088‏
996 ‎‡2 BNC|981058517188406706‏
996 ‎‡2 LIH|LNB:_d_Y_n_;=B7‏
996 ‎‡2 LC|no2009002537‏
996 ‎‡2 BNE|XX1062108‏
996 ‎‡2 DNB|1317649540‏
996 ‎‡2 ISNI|0000000059358585‏
996 ‎‡2 ISNI|000000006005006X‏
996 ‎‡2 BNC|981059289102706706‏
996 ‎‡2 BNC|981060402648006706‏
996 ‎‡2 ISNI|0000000416759943‏
996 ‎‡2 DNB|1019160926‏
996 ‎‡2 BNE|XX1610580‏
996 ‎‡2 BIBSYS|90771291‏
996 ‎‡2 BNF|16949324‏
996 ‎‡2 SUDOC|275533840‏
996 ‎‡2 LC|n 96031854‏
996 ‎‡2 ISNI|000000005983799X‏
996 ‎‡2 BNE|XX1048457‏
996 ‎‡2 SUDOC|231829264‏
996 ‎‡2 BNF|12389563‏
996 ‎‡2 LC|no2002074459‏
996 ‎‡2 BNC|981058581813606706‏
996 ‎‡2 BNE|XX1580513‏
996 ‎‡2 ISNI|0000000041065565‏
996 ‎‡2 SUDOC|027065006‏
996 ‎‡2 SUDOC|171416554‏
996 ‎‡2 RERO|A009287079‏
996 ‎‡2 ISNI|0000000115720324‏
996 ‎‡2 BNF|14478856‏
996 ‎‡2 SUDOC|171785940‏
996 ‎‡2 BNC|981058516359606706‏
996 ‎‡2 RERO|A013465371‏
996 ‎‡2 LC|n 97105849‏
996 ‎‡2 BNC|981058525020006706‏
996 ‎‡2 ISNI|0000000060116348‏
996 ‎‡2 LC|n 2024015467‏
996 ‎‡2 LC|no2019160480‏
996 ‎‡2 J9U|987007376335205171‏
996 ‎‡2 SZ|1075605245‏
996 ‎‡2 SUDOC|243673779‏
996 ‎‡2 RERO|A000134171‏
996 ‎‡2 DNB|1236915720‏
996 ‎‡2 SUDOC|14480008X‏
996 ‎‡2 ISNI|0000000026777839‏
996 ‎‡2 ISNI|0000000039133864‏
996 ‎‡2 BNE|XX1067030‏
996 ‎‡2 LC|n 80002210‏
996 ‎‡2 DNB|1056398191‏
996 ‎‡2 BNE|XX1095716‏
996 ‎‡2 NUKAT|n 00028810‏
996 ‎‡2 SUDOC|179935356‏
996 ‎‡2 BIBSYS|90554942‏
996 ‎‡2 LC|no2014086161‏
996 ‎‡2 BAV|495_257529‏
996 ‎‡2 BNC|981058527297906706‏
996 ‎‡2 ISNI|0000000060777613‏
996 ‎‡2 NTA|412025787‏
996 ‎‡2 ISNI|0000000059410574‏
996 ‎‡2 DNB|1158631588‏
996 ‎‡2 ARBABN|000052619‏
996 ‎‡2 BNE|XX993297‏
996 ‎‡2 ISNI|0000000021276023‏
996 ‎‡2 BNF|14611084‏
996 ‎‡2 BNF|17916184‏
996 ‎‡2 SUDOC|273351621‏
996 ‎‡2 ISNI|0000000059810412‏
996 ‎‡2 BNE|XX5153258‏
996 ‎‡2 BNE|XX1443172‏
996 ‎‡2 BNE|XX1569026‏
996 ‎‡2 SUDOC|200809822‏
996 ‎‡2 LC|ns2015003181‏
996 ‎‡2 BNE|XX4615085‏
996 ‎‡2 PLWABN|9810572330005606‏
996 ‎‡2 SUDOC|113158521‏
996 ‎‡2 NTA|07486114X‏
996 ‎‡2 LC|n 2018030232‏
996 ‎‡2 SUDOC|255899610‏
996 ‎‡2 ISNI|0000000088254486‏
996 ‎‡2 SUDOC|129039209‏
996 ‎‡2 BNF|16683395‏
996 ‎‡2 SUDOC|164491694‏
996 ‎‡2 J9U|987007342651505171‏
996 ‎‡2 PTBNP|661813‏
996 ‎‡2 LC|ns2022001363‏
996 ‎‡2 LC|no2016165404‏
996 ‎‡2 BNE|XX1045298‏
996 ‎‡2 BNC|981058605672806706‏
996 ‎‡2 ISNI|000000011818706X‏
996 ‎‡2 BNE|XX1138222‏
996 ‎‡2 BNE|XX5472268‏
996 ‎‡2 BNE|XX1715970‏
996 ‎‡2 RERO|A024080752‏
996 ‎‡2 BNE|XX1292994‏
996 ‎‡2 LC|n 2021252546‏
996 ‎‡2 BNE|XX5456973‏
996 ‎‡2 BLBNB|001416450‏
996 ‎‡2 LC|no2020065979‏
996 ‎‡2 ISNI|0000000364613474‏
996 ‎‡2 ISNI|0000000119522034‏
996 ‎‡2 BNE|XX5564724‏
996 ‎‡2 NKC|pna2015892529‏
996 ‎‡2 BNC|981058523126906706‏
996 ‎‡2 BNC|981061095862506706‏
996 ‎‡2 ISNI|0000000083986573‏
996 ‎‡2 SUDOC|113522444‏
996 ‎‡2 BNE|XX1673380‏
996 ‎‡2 BNE|XX852634‏
996 ‎‡2 ISNI|0000000116821143‏
996 ‎‡2 SUDOC|176093613‏
996 ‎‡2 BIBSYS|14011360‏
996 ‎‡2 DNB|1056186380‏
996 ‎‡2 DNB|1057461075‏
996 ‎‡2 SUDOC|02853770X‏
996 ‎‡2 ISNI|0000000066467114‏
996 ‎‡2 BNE|XX4604913‏
996 ‎‡2 DNB|1056576723‏
996 ‎‡2 BNE|XX1674033‏
996 ‎‡2 DNB|127172912‏
996 ‎‡2 BLBNB|000253246‏
996 ‎‡2 BNE|XX6373952‏
996 ‎‡2 LC|n 80054748‏
996 ‎‡2 ISNI|0000000067639694‏
996 ‎‡2 ISNI|0000000375362607‏
996 ‎‡2 RERO|A003718781‏
996 ‎‡2 LC|no2017161298‏
996 ‎‡2 PTBNP|648135‏
996 ‎‡2 BNE|XX5744960‏
996 ‎‡2 BNE|XX1076277‏
996 ‎‡2 LC|ns2023000788‏
996 ‎‡2 LC|n 98113326‏
996 ‎‡2 BNE|XX1253536‏
996 ‎‡2 SUDOC|060784725‏
996 ‎‡2 BNE|XX1167215‏
996 ‎‡2 LC|no 94023771‏
996 ‎‡2 ICCU|PUVV386741‏
996 ‎‡2 LC|no2001089896‏
996 ‎‡2 ISNI|0000000016150530‏
996 ‎‡2 ISNI|0000000059551780‏
996 ‎‡2 DNB|142490857‏
996 ‎‡2 SUDOC|15897669X‏
996 ‎‡2 DNB|1246388588‏
996 ‎‡2 SUDOC|232643660‏
996 ‎‡2 SUDOC|167609076‏
996 ‎‡2 LC|no 96038748‏
996 ‎‡2 NTA|134881680‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏